|
Company Watch
Glenmark gets tentative approval for Ondansetron
Our News Bureau - Mumbai
Glenmark
Pharmaceuticals, USA has received tentative approval from the USFDA for its
ANDA for Ondansetron Hydrochloride Tablets of four milligram (base), eight milligram
(base) and 24 milligram (base). Ondansetron Hydrochloride tablets are the generic
version of GSK's Zofram tablets. Ondansetron Hydrochloride belongs to a category
of anti-emetics and is prescribed to help control nausea and vomiting. The drug
had an annual sale of about $640 million, based on IMS data for the 12 months
ending June 30, 2006.
|